Companies/UK/CIR

NIOX GROUP PLC

Ownership & governance

Executives 5Directors 6Avg age 58Avg tenure 5.6y
Jonathan Emms
Chief Executive Officer
Since 2025-01-15Profile →

Shareholders5

NameStakeShares
Harwood Capital LLP
16.64 %
70,000,075
ASTRAZENECA PLC
15.71 %
66,111,281
Rathbones Investment Management Ltd.
9.925 %
41,753,708
Woodford Investment Management Ltd.
6.209 %
26,122,582
Raymond James Wealth Management Ltd. (Investment Management)
4.96 %
20,866,227

Catalog · 2026-07-09

Registry officers11

NameRoleSinceShares
Ian JohnsonChairman2019-12-04-
Jan LundquistChief Tech/Sci/R&D Officer—-
Jonathan EmmsChief Executive Officer2025-01-15-
Sarah DuncanDirector of Finance/CFO2025-05-13-
Garry WattsDirector/Board Member2020-03-01-
Jonathan EmmsDirector/Board Member2019-09-01-
Nicholas MillsDirector/Board Member2020-11-12-
Robert NaylorDirector/Board Member2024-06-30-

Registry · as of 2026-07-09

Group companies

NameCategory
NIOX Healthcare Ltd.Pharmaceuticals: Other
NIOX Healthcare Ltd.Pharmaceuticals: Other

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 82.4Range 77–86Analysts 5
77Mean 82.486
  • Buy 6

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers